[1]
F. Yang, W. Guo, S. Sun, i Y. Huang, „Combination of Prostate Cancer Antigen 3 (PCA3), Sarcosine, Glypican-1 (GPC1), Urokinase Plasminogen Activator Receptor (uPAR), and Thymidine Kinase 1 (TK1), and T2WI and DWI Radiomics Model for Distinguishing Benign Prostatic Hyperplasia, Prostate Cancer: -“, J Med Biochem, vol 44, izd. 6, str. 1376–1385, Juli 2025, doi: 10.5937/jomb0-57639.